Proteome Sciences (LON:PRM) Issues Quarterly Earnings Results

Proteome Sciences (LON:PRM) posted its earnings results on Wednesday. The company reported GBX (0.41) earnings per share (EPS) for the quarter, Digital Look Earnings reports. Proteome Sciences had a negative net margin of 81.50% and a positive return on equity of 33.80%.

Proteome Sciences Trading Up 12.9%

Shares of PRM traded up GBX 0.18 during mid-day trading on Friday, hitting GBX 1.58. 4,574,178 shares of the company’s stock traded hands, compared to its average volume of 400,438. The business’s 50-day moving average price is GBX 1.70 and its 200-day moving average price is GBX 1.63. The firm has a market capitalization of £5.54 million, a P/E ratio of -1.52 and a beta of 0.16. The company has a quick ratio of 0.37, a current ratio of 0.13 and a debt-to-equity ratio of -165.46. Proteome Sciences has a 1 year low of GBX 1.11 and a 1 year high of GBX 4.40.

About Proteome Sciences

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.